Stay updated on Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial
Sign up to get notified when there's something new on the Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial page.

Latest updates to the Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial page
- CheckyesterdayChange DetectedNo additions or deletions were detected on the page.SummaryDifference0.2%

- Check8 days agoChange DetectedPage revision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check15 days agoChange DetectedThe page now shows a Terminated status with a note that the decision was for business reasons and not related to safety concerns, and this termination detail is reflected in the Study Details section.SummaryDifference0.1%

- Check23 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3 in the footer.SummaryDifference0.2%

- Check30 days agoChange DetectedScreenshots depict the same study details page with no substantive content changes; any observed diffs appear cosmetic.SummaryDifference0.1%

- Check37 days agoChange DetectedTwo screenshots show only layout/navigation adjustments on the page. There are no changes to the study design, eligibility criteria, outcomes, enrollment, or current status.SummaryDifference0.1%

Stay in the know with updates to Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison of Crisaborole vs. TCS and TCI in AD Clinical Trial page.